Clinical Trials on Healthy Allogeneic Donors in Singapore

Total 189 results

National University Hospital, Singapore

Unknown

To Identify HLA-A1101-restricted Peptide Epitopes Derived From Novel Oncoantigens (URLC10, KIF20A, and CDCA1) Applicable for Cancer Vaccine in Singapore

Anonymous Donors at Blood Donation Center (NUH)

Singapore
National University of Singapore
Ministry of Health, Singapore

Recruiting

Continuous Observations of Behavioural Risk Factors in Asia (COBRA) (COBRA)

Physical Activity | Sleep | Sedentary Behavior | Health Behavior | Diet, Healthy

Singapore
KK Women's and Children's Hospital

Not yet recruiting

Targeted Fortification of Pasteurized Donor Human Milk

Growth Failure | Very Low Birth Weight Infant | Donor Breast Milk

Singapore
National Heart Centre Singapore

Recruiting

A Pilot Feasibility Study of Detection of IL-11 and Other Cytokines in the Exhaled Breath Condensate (EBC) and Blood of Healthy Volunteers

Healthy

Singapore
Wang Yongtai Raymond
The N.1 Institute for Health (N.1)

Not yet recruiting

Effects of Different Cardiorespiratory Training Program on Endurance Performance

Healthy

Singapore
Nanyang Technological University
University of Cambridge

Completed

Structure Learning Training and Cognitive Flexibility

Healthy

Singapore
Eli Lilly and Company

Completed

A Study to Compare Two Formulations of LY3819469 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Multiple-Dose Study of LY3493269 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY3871801 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY3493269 in Healthy Participants

Healthy

Singapore
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Food Effect Study For New Formulation

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of a New LY900014 Formulation in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

Study to Compare 2 Formulations of LY900014 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY900014 Formulation in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Safety Study of LY3462817 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY3374849 in Healthy Participants

Healthy

Singapore
Pfizer

Terminated

A Study To Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy Subjects

Healthy

Singapore
Eli Lilly and Company

Completed

A Study Comparing Two Formulations of Insulin Glargine in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study to Compare LY2963016 and US-approved Lantus® After Single Dose Administration to Healthy Participants

Healthy

Singapore
Pfizer

Completed

A Phase 1 Study To Evaluate The Pharmacokinetics (PK), Safety, And Bioavailability Of A Modified-Release (MR) Formulation Of Tofacitinib In Healthy Volunteers

Healthy

Singapore
Pfizer

Completed

A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804

Healthy

Singapore
Pfizer

Completed

A Study In Healthy Volunteers To Assess The Safety, Tolerability, And Relative Oral Bioavailability Of Three Formulations Of PH-797804

Healthy

Singapore
Pfizer

Completed

A Study To Evaluate The Safety, Tolerability And Plasma Drug Levels Of PF-04447943 When Administered With Donepezil To Healthy Volunteer Subjects

Healthy

Singapore
Pfizer

Completed

A Study In Healthy People To Investigate The Safety, Toleration And Time Course Of Blood Concentrations Of Multiple Doses Of PF-03654764, Given By Mouth

Healthy

Singapore
National University, Singapore
Health Promotion Board, Singapore

Recruiting

Health@NUS - Studying Health Behaviours and Well-being During the Student-to-Work Life Transition Using mHealth

Healthy

Singapore
Eli Lilly and Company

Completed

A Study to Compare Two Formulations of LY3209590 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of Lasmiditan in Healthy Volunteers

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of Continuous Blood Pressure Monitoring in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants

Healthy

Singapore
Clinical Nutrition Research Centre, Singapore

Completed

The Effects on Glycemic and Insulinemic Responses by Fruit Consumption (TGIF)

Healthy

Singapore
Eli Lilly and Company

Completed

A Safety Study of LY3493269 in Healthy Participants

Healthy

Singapore
Danone Asia Pacific Holdings Pte, Ltd.
Techobserver

Completed

A Proof of Concept Study to Investigate the Use and Relevance of a Digital Platform for Infant Crying and Fussing (COOL)

Healthy

Singapore
Eli Lilly and Company

Completed

A Safety Study of LY3493269 Given as a Single Injection in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of Various Formulations of LY900014 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY900020 in Healthy Chinese Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY3185643 and rGlucagon in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of Baricitinib in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of Different Particle Sizes of Evacetrapib in Healthy Participants

Healthy

Singapore
Pfizer

Completed

A Phase 1 Study To Evaluate The Pharmacokinetics And Safety Of Three Modified Release And One Immediate Release Formulations Of Tofacitinib (CP-690,550) In Healthy Volunteers

Healthy

Singapore
Pfizer

Completed

Food Effect Study For Apixaban Commercial Image Tablets

Healthy

Singapore
Pfizer

Completed

Phase1, Single Dose, Crossover Study to Determine Bioequivalence

Healthy

Singapore
Pfizer

Completed

A Multiple Dose Study To Determine Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Healthy Adult Subjects

Healthy

Singapore
Clinical Nutrition Research Centre, Singapore

Active, not recruiting

Effects of the Consumption of SEAweed Biomass Versus PROtein Isolates on Postprandial Satiety and Metabolism (SEAPRO)

Nutrition, Healthy

Singapore
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Pharmacokinetics of Two Eletriptan Oral Formulations Given With and Without Water and the Commercial Tablet Formulation Given With Water

Healthy Volunteers

Singapore
Biogen

Completed

First-in-Human Study of PF-04958242 in Healthy Volunteers

Healthy Volunteer

Singapore
Innosparks Pte Ltd.
National University Hospital, Singapore; KK Women's and Children's Hospital

Completed

A Randomised Crossover Study to Explore the Physiological Impact of AIR+ Smart Masks on Children

Healthy Subjects

Singapore
Eli Lilly and Company

Completed

A Study of LY3053102 in Healthy Participants

Healthy Volunteers

Singapore
Eli Lilly and Company

Completed

A Study of LY3025876 in Healthy Volunteers

Healthy Volunteers

Singapore

3

Subscribe